88IV - PR Newswire Asia's news


Prota Therapeutics' CEO Mimi Tang honoured at BioMelbourne Network's Women in Leadership Awards 2024 MELBOURNE, Australia , April 29, 2024 /PRNewswire/ -- Prota Therapeutics ' CEO Professor Mimi Tang has been honoured in the prestigious 2024 BioMelbourne Network Women in Leadership Awards. Professor ... 2024-04-29T Biotechnology Health Care/Hospital
Ractigen Therapeutics Announces FDA Approval for RAG-01, a First-in-Class saRNA Therapy for BCG-Unresponsive NMIBC SUZHOU, China , April 26, 2024 /PRNewswire/ -- Ractigen Therapeutics, a leader in the development of small activating RNA (saRNA) therapeutics, announced today that the U.S. Food and Drug Administration ... 2024-04-26T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Novel T-cell engager, CDH17 X CD3 cabotamig (ARB202) continues to explore dosing in patients with advanced gastrointestinal cancers The second DMC review recommends the continuation of dose escalation in the clinical trial as per protocol. The interim safety assessment was based on the review of safety data from 18 metastatic gastrointestinal ... 2024-04-26T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Fosun Pharma's Self-developed Artemisinin Medicines Inject New Impetus to Malaria Prevention and Treatment in Africa SHANGHAI , April 26, 2024 /PRNewswire/ -- World Malaria Day is marked each year on April 25 . World Health Organization (WHO) gave as the theme for World Malaria Day 2024 Accelerating the fight ... 2024-04-26T Biotechnology Health Care/Hospital Infectious Disease Control Medical/Pharmaceuticals
Hyosung TNC presents a new paradigm through sustainable bio BDO production. SEOUL, South Korea , April 26, 2024 /PRNewswire/ -- Hyosung TNC is taking significant strides towards a sustainable future by focusing on the production of sustainable bio-based BDO. Butanediol ... 2024-04-26T Biotechnology Environmental Products & Services Green Technology
Caliway Announced CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary Endpoints CBL-514 is the first product to treat cellulite at the raised areas. Currently, there is no effective and safe cellulite treatment on the market. The global market for cellulite treatment is estimated ... 2024-04-26T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
2024 ASCO \| Mabwell to Present Clinical Data of 9MW2821 in Multiple Advanced Solid Tumor SHANGHAI , April 25, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with an entire industry chain, announced that the Phase I/II clinical study results of ... 2024-04-25T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Hyundai Bioscience's antiviral for Dengue Fever to enter clinical trials in Brazil "Aiming to offer a Dengue antiviral treatment course in $100 price range" Hyundai Bioscience decides to conduct dengue clinical trials in Brazil , which has the largest number of Dengue ... 2024-04-25T Biotechnology Health Care/Hospital Infectious Disease Control Medical/Pharmaceuticals
Antengene Announces One Oral and Three Poster Presentations at ASCO 2024 Oral session： ATG-008 (mTORC1/2 Inhibitor) combined with PD-1 antibody in Phase II studies for cervical cancer Three Poster presentations: Phase I/II studies for ATG-031 (anti-CD24 monoclonal ... 2024-04-25T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Onconic Therapeutics Receives MFDS Approval for JAQBO, a New Treatment for Gastroesophageal Reflux Disease (GERD) SEOUL, South Korea , April 25, 2024 /PRNewswire/ -- Onconic Therapeutics, a leading biotechnology company in Korea, today announced that the Ministry of Food and Drug Safety (MFDS) of Korea has approved ... 2024-04-25T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Biotechnology